Tox21_202839

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

16 Suppliers, 4 USDMF, 6 CEP/COS, 2 JDMF, 3 EU WC, 2 KDMF, 12 NDC API, 13 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

DOSSIERs // Finished Dosage Forms

101 Dossiers, 30 FDA Orange Book, 38 Europe, 32 Canada, 1 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - 0.25%, INJECTABLE;INJECTION - 0.25%;0.0091MG/ML, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 0.5%;0.0091MG/ML, INJECTABLE;INJECTION - 0.75%, INJECTABLE;INJECTION - 0.75%;0.0091MG/ML, INJECTABLE;INJECTION - 0.25%, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 0.5%;0.0091MG/ML, INJECTABLE;INJECTION - 0.75%, INJECTABLE;INJECTION - 0.75%;0.0091MG/ML, INJECTABLE;INJECTION - 4%; EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML), INJECTABLE;INJECTION - 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML), INJECTABLE;INJECTION - 0.5%;0.0091MG/ML, INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%, INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

RELATED EXCIPIENT COMPANIES

Suppliers, 4 Actylis, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl

GLOBAL SALES INFORMATION

26 Finished Drug Prices

26 Finished Drug Prices

MARKET PLACE

24 APIs, 3 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

6 EDQM Standards, 1 USP Standards, 2 JP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

9 News

9 News

List of JP reference standards related to Tox21_202839

Tox21_202839

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

16 Suppliers

4 USDMF

6 CEP/COS

2 JDMF

3 EU WC

2 KDMF

12 NDC API

13 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

DOSSIERs // Finished Dosage Forms

101 Dossiers

30 FDA Orange Book

38 Europe

32 Canada

1 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - 0.25%

INJECTABLE;INJECTION - 0.25%;0.0091MG/ML

INJECTABLE;INJECTION - 0.5%

INJECTABLE;INJECTION - 0.5%;0.0091MG/ML

INJECTABLE;INJECTION - 0.75%

INJECTABLE;INJECTION - 0.75%;0.0091MG/ML

INJECTABLE;INJECTION - 0.25%

INJECTABLE;INJECTION - 0.5%

INJECTABLE;INJECTION - 0.5%;0.0091MG/ML

INJECTABLE;INJECTION - 0.75%

INJECTABLE;INJECTION - 0.75%;0.0091MG/ML

INJECTABLE;INJECTION - 4%; EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML)

INJECTABLE;INJECTION - 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML)

INJECTABLE;INJECTION - 0.5%;0.0091MG/ML

INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%

INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

RELATED EXCIPIENT COMPANIES

Suppliers

4 Actylis

1 Nanjing Well Pharmaceutical

1 Pfanstiehl

GLOBAL SALES INFORMATION

26 Finished Drug Prices

MARKET PLACE

24 APIs

3 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

6 EDQM Standards

1 USP Standards

2 JP Standards

1 Other Ref. Standards

DIGITAL CONTENT

9 News

Tox21_202839

REFERENCE STANDARDS// JP

Japanese Pharmacopoeia

Noradrenaline

P/ CC

50 mg

8°C

13,526

REFERENCE STANDARDS// JP

Japanese Pharmacopoeia

Noradrenaline Injection

P/ CC

50 mg

8°C

13,526